Figtree Pharmacy Raises Seed Funding From AJVC Fund

Why It Matters

The infusion of capital enables Figtree to scale a small‑format, repeat‑customer‑driven model that could reshape urban pharmacy retail in India, challenging larger chains. Its focus on logistics and private‑label products positions it to capture higher margins in a rapidly digitizing market.

Key Takeaways

• Figtree aims for 25 stores, expanding beyond Mumbai and Delhi
• Seed round led by AJVC Fund, amount undisclosed
• Over 90% repeat customers, average order $12 (Rs 1,000)
• Focus on small-format, hyperlocal pharmacies versus large retail chains
• Funding will boost logistics, tech stack, and private‑label medicines

Pulse Analysis

India’s pharmacy sector is undergoing a digital transformation, with consumers increasingly favoring convenience and speed. Traditional large‑format chains dominate shelf space, but they often struggle to meet hyperlocal demand in dense urban neighborhoods. Startups like Figtree Pharmacy are leveraging compact store footprints and data‑driven inventory to serve customers within a few blocks, mirroring the success of quick‑commerce models in food delivery. This approach not only reduces real‑estate costs but also aligns with Indian shoppers’ preference for repeat purchases of everyday medicines, as evidenced by Figtree’s 90% repeat‑customer rate.

The seed investment from AJVC Fund signals confidence in the viability of hyperlocal pharmacy concepts. AJVC, known for backing early‑stage tech and consumer ventures, adds strategic value beyond capital, offering mentorship in scaling logistics and technology platforms. While the exact amount remains undisclosed, the funding earmarked for logistics, tech stack enhancements, and private‑label drug development suggests a roadmap toward operational efficiency and higher margin products. In a market where the average pharmacy transaction is roughly $12, improving supply chain speed can translate into significant revenue uplift as the network expands to 25 stores.

Looking ahead, Figtree’s expansion could intensify competition among urban pharmacy players, prompting incumbents to rethink store formats and digital offerings. The emphasis on private‑label medicines may also disrupt traditional brand‑centric supply chains, offering consumers lower‑priced alternatives while boosting the startup’s profitability. If Figtree successfully scales its repeat‑customer base and maintains high order values, it could set a benchmark for future pharmacy ventures aiming to combine localized service with tech‑enabled efficiency, reshaping the Indian retail pharmacy landscape.

Deal Summary

Mumbai-based pharmacy startup Figtree Pharmacy announced it has closed a seed funding round led by AJVC Fund, with participation from other investors. The undisclosed amount will be used to strengthen logistics, build its technology stack, launch private‑label medicines, and expand its store network to 25 locations. Founded in 2025 by former Nomura analyst Adrit Chaturvedi and Yatin Sharma, the company currently operates four stores in Mumbai and one in Delhi.